Bristol Myers Squibb (BMS) has announced positive phase 3 results for Opdivo (nivolumab) in combination with Yervoy ...
As we move forward in 2024, the healthcare industry has embraced the idea that AI-generated synthetic patients are here for the long haul. The remarkable ability to utilize artificial patients that ...
Takeda’s HyQvia has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a maintenance therapy for the rare neurological disorder chronic inflammatory demyelinating ...
Vynamic, an Inizio Advisory company, has announced the promotion of Gemma Pfister as head of life sciences, Europe. Pfister holds over two decades of experience in strategy consulting and business ...